期刊文献+

离子交换层析法制备高纯度人凝血因子Ⅷ的研究 被引量:6

Preparation of high purity human coagulation factor Ⅷ using ion exchange chromatography
原文传递
导出
摘要 目的:从血浆冷沉淀中采用离子交换层析法纯化人凝血因子Ⅷ。方法:冰冻血浆在2~8℃环境下融化,离心法收获冷沉淀。用注射用水溶解冷沉淀,探索了5种冷沉淀溶解液预纯化的方法。冷沉淀溶解液经S/D病毒灭活后采用离子交换层析纯化人凝血因子Ⅷ,经超滤、配制、除菌分装、冻干、干热病毒灭活,获得人凝血因子Ⅷ成品,分别检测流穿液、洗涤液和洗脱液中人凝血因子Ⅷ效价和蛋白含量。观察了冻干和不同干热条件前后凝血因子Ⅷ活性的变化。观察人凝血因子Ⅷ冻干品的外观和复溶时间。结果:冷沉淀中人凝血因子Ⅷ的回收率为40%~70%。5种冷沉淀溶解液预纯化方法中,用盐酸调节p H至6.6、6.3的方法人凝血因子Ⅷ回收率较高。离子交换层析流穿液中FⅧ损失率小于5%,而洗涤液中FⅧ损失率较高,最高损失率超过20%。人凝血因子Ⅷ中蛋白质含量较低,均小于0.65 mg·m L-1,比活性为50~100IU·m L-1。吐温-80和TNBP的残留量均符合《中国药典》的要求。冻干过程中人凝血因子Ⅷ效价下降大约1%~5%。100℃,30 min干热处理对FⅧ效价的破坏小于80℃,72 h。人凝血因子Ⅷ冻干品外观和复溶时间均达到中国药典标准。结论:采用离子交换层析法从血浆冷沉淀中分离出高纯度人凝血因子Ⅷ,可以进行工艺放大研究。 Objective: To purify coagulation factor Ⅷ from human plasma using ion exchange chromatography. Methods: The cryoprecipitate was harvested by using centrifugation after thawing of fresh frozen plasma under2 ~ 8 ℃. The cryoprecipitate was dissolved with water for injection,and five prepurification methods of dissolved cryoprecipitate liquid were explored. The coagulation factor Ⅷ was purified by using ion exchange chromatography after inactivation of virus followed by ultrafiltration,preparation,aseptic packaging,lyophilization,and dry heat inactivation of virus to obtain the final products. The activity and protein content of coagulation factor Ⅷ in the flowing through liquid,washing liquid,and elution liquid were determined. The activities of coagulation factor Ⅷ products undering lyophilizatio and dry heat inactivation of virus were compared. The appearance and dissolving time of coagulation factor Ⅷ were observed. Results: The recovery of coagulation factor Ⅷ activity was 40% ~ 70% from frozen plasma after centrifugating. The recoveries at p H 6. 6 and 6. 3 were higher among the five methods. The loss ratio of flow though was less than 5%,and the top loss ratio of washing reached 20%. The protein content of coagulation factor Ⅷ was less than 0. 65 mg·m L- 1,and the specific activity was 50 ~ 100 IU·m L- 1. The residue amount of Teween-80 and tributyl phosphate conformed to the standard of Chinese Pharmacopoeia. The activity of coagulation factor Ⅷ decreased by about 1% ~ 5% after lyophilizatio,and the activity was decreased in a smaller magnitude by dry heat under the condition of 100 ℃ 30 min than that under 80 ℃ 72 h. The appearance and dissol-ving time of coagulation factor Ⅷ purified by ion exchange chromatography met the standards. Conclusion: High purity coagulation factor Ⅷ can be obtained by using ion exchange chromatography and this process can be scaled-up.
出处 《中国新药杂志》 CAS CSCD 北大核心 2015年第7期760-764,799,共6页 Chinese Journal of New Drugs
关键词 人凝血因子Ⅷ 离子交换层析 冷沉淀 血浆 human coagulation factor Ⅷ ion exchange chromatography cryoprecipitate plasma
  • 相关文献

参考文献6

  • 1梁小明,黄璠,周星,何淑琴,刘敏亮.人凝血因子Ⅷ的提取工艺研究[J].安徽农业科学,2013,41(30):12043-12044. 被引量:5
  • 2MORI F, NARDINI I, ROSSI P,ei al. Progress in large-scale puri-fication of factor Vl/von Willebrand factor concentrates using ion-exchange Chromatography [ J]. Vox Sanguinis,2008 , (95 ) :298 -307.
  • 3FREEDMAN M,ROCK G. Analysis of the products of cryoprecipi-tation : RiCoF is deficient in cryosupernatant plasma [ J ]. TransfusApher Sci, 2010,43(2) :179 - 182.
  • 4CHENG E,JIN D,ALMEIDA AP,e( al. Purification of coagulationfactor VK using chromatographic methods. Direct chromatography ofplasma in anion exchange resins [ J ]. Biotechnol Letty 2010, 32(9):1207 -1214.
  • 5邓志华,何淑琴,梁小明,张丽铃,黄璠.人凝血因子Ⅷ提取工艺优化研究[J].江西医药,2014,49(2):107-109. 被引量:4
  • 6李策生,周志军,胡勇,邢延涛,李陶敬,林连珍,彭焱,邹光荣.人凝血因子Ⅷ中试纯化工艺的质量控制[J].中国生物制品学杂志,2013,26(10):1508-1512. 被引量:12

二级参考文献25

  • 1Brooker M. Registry of Clotting Factor Concentrates [M]. Eighth Edition. Montr6al, Qu6bec, Canada: World Federation of Hemo- philia, 2008.
  • 2Wagner BH, McLester WD, Smith M, et o2. Purification of anti- hemophilic factor (factor V) by amino acid precipitation [J]. Thromh Diath Haemorrh, 1964, 11 (1): 64-74.
  • 3Newman J, Johnson AJ, Karpatkin MH, et al. Methods for the production of clinically effective intermediate- and high-purity factor-V concentrates [J]. Br J Haematol, 1971, 21 ( 1 ): 1-20.
  • 4Burnouf T, Bumouf-Radosevich M, Huart JJ, et o/. A highly purified faetor V:c concentrate prepared from cryoprecipitate by ion-exchange chromatography [J]. Vox Sang, 1991, 60 (1): 8- 15.
  • 5Cheng E, Jinzenji D, Lorthiois AP, et al. Purification of coagu- lation factor V using chromatographic methods. Direct chroma- tography of plasma in anion exchange resins [J]. Biotechnol Lett, 2010, 32 (9): 1207-1214.
  • 6Teh LC, Froger M. Direct capture of plasma factor vm:c by ion exchange chromatography [J]. Vox Sang, 1994, 67 ( 1 ): 8-13.
  • 7Kaersgaard P, Barington KA. Isolation of the factor VW-von Willebrand factor complex directly from plasma by gel filtration [J]. J Chromatogr B Biomed Sci Appl, 1998, 715 (2): 357-367.
  • 8Teh LC. Preparation of intermediate-purity factor V concentrate by direct gel filtration of cryoprecipitate [J]. Vox Sang, 1993, 65 (4): 251-257.
  • 9Wadsworth C, Blomback M, Kjellman H, et ol. Complexes of IgG and plasma proteins in factor Vm preparations-a possible cause of adverse reactions [J]. Vox Sang, 1985, 49 (5): 319-322.
  • 10Vlot AJ, Koppelman SJ, Van Den Berg MH, et ol. The affinity and stoiehiometry of binding of human factor VIII to yon Willebrand factor [J]. Blood, 1995, 85 ( 11 ): 3150-3157.

共引文献13

同被引文献38

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部